{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:31:48Z","timestamp":1782977508523,"version":"3.54.5"},"publisher-location":"Cham","reference-count":26,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030273774","type":"print"},{"value":"9783030273781","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-27378-1_91","type":"book-chapter","created":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T18:02:49Z","timestamp":1577556169000},"page":"557-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Mini Review: Moving iPSC-Derived Retinal Subtypes Forward for Clinical Applications for Retinal Degenerative Diseases"],"prefix":"10.1007","author":[{"given":"Chloe","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu T.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,29]]},"reference":[{"issue":"6","key":"91_CR1","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.ajhg.2016.10.008","volume":"99","author":"G Arno","year":"2016","unstructured":"Arno G, Agrawal SA, Eblimit A, Bellingham J, Xu M, Wang F et al (2016) Mutations in REEP6 cause autosomal-recessive retinitis pigmentosa. Am J Hum Genet 99(6):1305\u20131315","journal-title":"Am J Hum Genet"},{"key":"91_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.scr.2018.01.009","volume":"27","author":"TT Duong","year":"2018","unstructured":"Duong TT, Vasireddy V, Ramachandran P, Herrera PS, Leo L, Merkel C et al (2018) Use of induced pluripotent stem cell models to probe the pathogenesis of Choroideremia and to develop a potential treatment. Stem Cell Res 27:140\u2013150","journal-title":"Stem Cell Res"},{"issue":"3","key":"91_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.stemcr.2018.07.005","volume":"11","author":"G Gagliardi","year":"2018","unstructured":"Gagliardi G, Ben M'Barek K, Chaffiol A, Slembrouck-Brec A, Conart J-B, Nanteau C et al (2018 Sep 11) Characterization and transplantation of CD73-positive photoreceptors isolated from human iPSC-derived retinal organoids. Stem Cell Reports 11(3):665\u2013680","journal-title":"Stem Cell Reports"},{"issue":"39","key":"91_CR4","doi-asserted-by":"publisher","first-page":"E8214","DOI":"10.1073\/pnas.1710430114","volume":"114","author":"CA Galloway","year":"2017","unstructured":"Galloway CA, Dalvi S, Hung SSC, MacDonald LA, Latchney LR, Wong RCB et al (2017) Drusen in patient-derived hiPSC-RPE models of macular dystrophies. Proc Natl Acad Sci U S A 114(39):E8214\u2013E8223","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"91_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.5966\/sctm.2012-0005","volume":"1","author":"Z-B Jin","year":"2012","unstructured":"Jin Z-B, Okamoto S, Xiang P, Takahashi M (2012) Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling. Stem Cells Transl Med 1(6):503\u2013509","journal-title":"Stem Cells Transl Med"},{"issue":"435","key":"91_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao4097","volume":"10","author":"AH Kashani","year":"2018","unstructured":"Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Dang W et al (2018) A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration. Sci Transl Med 10(435):eaao4097","journal-title":"Sci Transl Med"},{"key":"91_CR7","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.stemcr.2018.02.010","volume":"10","author":"KB Langer","year":"2018","unstructured":"Langer KB, Ohlemacher SK, Phillips MJ, Fligor CM, Jiang P, Gamm DM et al (2018) Retinal ganglion cell diversity and subtype specification from human pluripotent stem cells. Stem Cell Reports 10:1282","journal-title":"Stem Cell Reports"},{"issue":"5","key":"91_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1089\/jop.2016.0022","volume":"32","author":"LL Leach","year":"2016","unstructured":"Leach LL, Croze RH, Hu Q, Nadar VP, Clevenger TN, Pennington BO et al (2016) Induced pluripotent stem cell-derived retinal pigmented epithelium: a comparative study between cell lines and differentiation methods. J Ocul Pharmacol Ther 32(5):317\u2013330","journal-title":"J Ocul Pharmacol Ther"},{"issue":"9","key":"91_CR9","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1038\/mt.2014.100","volume":"22","author":"Y Li","year":"2014","unstructured":"Li Y, Wu W-H, Hsu C-W, Nguyen HV, Tsai Y-T, Chan L et al (2014) Gene therapy in patient-specific stem cell lines and a preclinical model of retinitis pigmentosa with membrane frizzled-related protein defects. Mol Ther 22(9):1688\u20131697","journal-title":"Mol Ther"},{"key":"91_CR10","doi-asserted-by":"publisher","first-page":"12910","DOI":"10.1038\/srep12910","volume":"5","author":"D Lukovic","year":"2015","unstructured":"Lukovic D, Castro AA, Delgado ABG, de los Angeles Mart\u00edn Bernal M, Pelaez NL, Lloret AD et al (2015) Human iPSC derived disease model of MERTK-associated retinitis pigmentosa. Sci Rep 5:12910","journal-title":"Sci Rep"},{"key":"91_CR011","doi-asserted-by":"crossref","unstructured":"Mandai M, Watanabe A, Kurimoto Y et al (2017) Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. N Engl J Med 376(11):1038\u20131046","DOI":"10.1056\/NEJMoa1608368"},{"issue":"6","key":"91_CR11","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/stem.2356","volume":"34","author":"SK Ohlemacher","year":"2016","unstructured":"Ohlemacher SK, Sridhar A, Xiao Y, Hochstetler AE, Sarfarazi M, Cummins TR et al (2016) Stepwise differentiation of retinal ganglion cells from human pluripotent stem cells enables analysis of glaucomatous neurodegeneration. Stem Cells 34(6):1553\u20131562","journal-title":"Stem Cells"},{"key":"91_CR12","doi-asserted-by":"crossref","first-page":"251584141877443","DOI":"10.1177\/2515841418774433","volume":"10","author":"J Oswald","year":"2018","unstructured":"Oswald J, Baranov P (2018) Regenerative medicine in the retina: from stem cells to cell replacement therapy. Ther Adv Ophthalmol 10:2515841418774433","journal-title":"Ther Adv Ophthalmol"},{"issue":"6","key":"91_CR13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.stem.2016.03.021","volume":"18","author":"DA Parfitt","year":"2016","unstructured":"Parfitt DA, Lane A, Ramsden CM, Carr A-JF, Munro PM, Jovanovic K et al (2016) Identification and correction of mechanisms underlying inherited blindness in human iPSC-derived optic cups. Cell Stem Cell 18(6):769\u2013781","journal-title":"Cell Stem Cell"},{"issue":"10097","key":"91_CR14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","volume":"390","author":"S Russell","year":"2017","unstructured":"Russell S, Bennett J, Wellman JA, Chung DC, Yu Z-F, Tillman A et al (2017) Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 390(10097):849\u2013860","journal-title":"Lancet"},{"issue":"4","key":"91_CR15","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/hmg\/ddu509","volume":"24","author":"N Schwarz","year":"2015","unstructured":"Schwarz N, Carr A-J, Lane A, Moeller F, Chen LL, Aguil\u00e0 M et al (2015) Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells. Hum Mol Genet 24(4):972\u2013986","journal-title":"Hum Mol Genet"},{"issue":"13","key":"91_CR16","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1093\/hmg\/ddx143","volume":"26","author":"N Schwarz","year":"2017","unstructured":"Schwarz N, Lane A, Jovanovic K, Parfitt DA, Aguil\u00e0 M, Thompson CL et al (2017) Arl3 and RP2 regulate the trafficking of ciliary tip kinesins. Hum Mol Genet 26(13):2480\u20132492","journal-title":"Hum Mol Genet"},{"issue":"2","key":"91_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.celrep.2017.06.045","volume":"20","author":"H Shimada","year":"2017","unstructured":"Shimada H, Lu Q, Insinna-Kettenhofen C, Nagashima K, English MA, Semler EM et al (2017) In vitro modeling using ciliopathy-patient-derived cells reveals distinct cilia dysfunctions caused by CEP290 mutations. Cell Rep 20(2):384\u2013396","journal-title":"Cell Rep"},{"issue":"11","key":"91_CR18","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/sctm.17-0059","volume":"6","author":"VM Sluch","year":"2017","unstructured":"Sluch VM, Chamling X, Liu MM, Berlinicke CA, Cheng J, Mitchell KL et al (2017) Enhanced stem cell differentiation and immunopurification of genome engineered human retinal ganglion cells. Stem Cells Transl Med 6(11):1972\u20131986","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"91_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/stem.2513","volume":"35","author":"P Teotia","year":"2017","unstructured":"Teotia P, Chopra DA, Dravid SM, Van Hook MJ, Qiu F, Morrison J et\u00a0al (2017a) Generation of functional human retinal ganglion cells with target specificity from pluripotent stem cells by chemically defined recapitulation of developmental mechanism. Stem Cells 35(3):572\u2013585","journal-title":"Stem Cells"},{"issue":"11","key":"91_CR20","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/stem.2675","volume":"35","author":"P Teotia","year":"2017","unstructured":"Teotia P, Van Hook MJ, Wichman CS, Allingham RR, Hauser MA, Ahmad I (2017b) Modeling Glaucoma: retinal ganglion cells generated from induced pluripotent stem cells of patients with SIX6 risk allele show developmental abnormalities. Stem Cells 35(11):2239\u20132252","journal-title":"Stem Cells"},{"issue":"11","key":"91_CR21","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y-C Tham","year":"2014","unstructured":"Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121(11):2081\u20132090","journal-title":"Ophthalmology"},{"issue":"5","key":"91_CR22","doi-asserted-by":"publisher","first-page":"e61396","DOI":"10.1371\/journal.pone.0061396","volume":"8","author":"V Vasireddy","year":"2013","unstructured":"Vasireddy V, Mills JA, Gaddameedi R, Basner-Tschakarjan E, Kohnke M, Black AD et al (2013) AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models. PLoS One 8(5):e61396\u2013e61313","journal-title":"PLoS One"},{"issue":"7","key":"91_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.21037\/sci.2017.07.02","volume":"4","author":"LS Weed","year":"2017","unstructured":"Weed LS, Mills JA (2017) Strategies for retinal cell generation from human pluripotent stem cells. Stem Cell Investig 4(7):65\u201365","journal-title":"Stem Cell Investig"},{"issue":"1","key":"91_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep30742","volume":"6","author":"LA Wiley","year":"2016","unstructured":"Wiley LA, Burnight ER, DeLuca AP, Anfinson KR, Cranston CM, Kaalberg EE et al (2016) cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness. Sci Rep 6(1):30742","journal-title":"Sci Rep"},{"key":"91_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1756-6606-7-45","volume":"7","author":"T Yoshida","year":"2014","unstructured":"Yoshida T, Ozawa Y, Suzuki K, Yuki K, Ohyama M, Akamatsu W et al (2014) The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa. Mol Brain 7:45. Bio Med Central. 2014;7(1):45\u201311.","journal-title":"Mol Brain"}],"container-title":["Advances in Experimental Medicine and Biology","Retinal Degenerative Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-27378-1_91","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T09:13:11Z","timestamp":1586423591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-27378-1_91"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030273774","9783030273781"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-27378-1_91","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"29 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}